Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB26FDQDT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,673
Award facts
- Contract value 100% obligated
- $1,673.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,673.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of TYMLOS 80 MCG Dose Pen Injector (1.56ML). This firm fixed-price delivery order was issued on October 22, 2025, with an ultimate completion date of October 23, 2025, and carries no set-aside designation. DMS Pharmaceutical Group Inc. is competing in the unrestricted federal procurement market based on demonstrated competitive capability and established performance within the Defense Logistics Agency's supply chain.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to provide comprehensive pharmaceutical support to military healthcare facilities worldwide. The underlying IDC, designated SPE2DR and valued at $499.999 billion, extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional pharmaceutical supplier for Department of Defense healthcare operations. The vendor's product portfolio encompasses a broad range of pharmaceuticals including specialty biologics, oncology treatments, vaccines, and emergency medications, with consistent delivery order performance demonstrating capability to support the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FDQDT?
SPE2DB26FDQDT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FDQDT worth?
The government has obligated $1,673 on SPE2DB26FDQDT.
Is contract SPE2DB26FDQDT an order under another contract?
Yes. SPE2DB26FDQDT is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB26FDQDT competed?
The extent of competition for SPE2DB26FDQDT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award